More harmonisation in EU clinical trials on the cards
This article was originally published in Scrip
An assessment of the European Clinical Trials Directive could lead to greater harmonisation among member states, said Dr Martin Terberger, head of the pharmaceutical unit in the European Commission's enterprise and industry directorate general, speaking at the DIA Euro meeting in Berlin this week.
You may also be interested in...
While information sharing is key to cross-country collaborations on access to medicines and can lead to major benefits, it is hard to sell to political leaders and the media, says a report from the World Health Organization’s regional office for Europe.
The European Commission says it will publish its review of the EU orphan drug legislation in the coming days.
The UK has formally withdrawn its ratification of the Unified Patent Court Agreement, adding to the uncertainty over its future.